Indicative MarketVIEW pricing
VacZine Analytics MarketVIEW studies combine strategic market analysis with a fully interactive, editable Microsoft Excel forecast model. Standard global team licences for emerging and pre-launch vaccine opportunities start from £8,995 for forecast summary outputs, or £12,995 with the fully interactive model. Established commercial markets and flagship vaccine categories are priced separately because they require broader segmentation, historical datasets and more extensive country-level modelling.
Priced according to analytical complexity.
We price by analytical complexity, market maturity and model breadth. The categories below indicate the appropriate pricing level for each type of study; your written quotation confirms the exact scope.
Emerging Opportunity MarketVIEW
Pipeline or pre-launch vaccine markets: limited existing sales and a relatively concentrated competitive landscape.
-
Bottom-up, fully interactive demand forecast model including DemandENGINE™ technology (Excel .xlsx file, downloadable)
DemandENGINE™ is VacZine Analytics' AI-enabled forecasting technology. It tracks every patient from first dose to booster, never double-counting, across age groups, risk groups and payer channels. Shape the launch uptake curve, set how fast protection wanes and when boosters are due, adjust compliance across the schedule, or switch funding decisions on and off, and see the whole market respond in seconds.
- Executive strategic presentation (PDF file, downloadable)
- One-hour post-delivery walkthrough with a senior analyst
- Defined free support period, 1 month post-delivery*
- Extra analyst support packages available
- Standard global team licenceUp to 10 users, with access to the online members area.
Forecast summary outputs only, without the fully interactive model: £8,995. The executive strategic presentation is still included, based on the forecast outputs.
- Bottom-up, fully interactive demand forecast model including DemandENGINE™ technology (online access only, not downloadable)
- Executive strategic presentation (online access only, not downloadable)
- One-hour post-delivery walkthrough with a senior analyst
- Defined free support period, 1 month post-delivery*
- Extra analyst support packages available
- Single seat licence - one named user, one login
Established Market MarketVIEW
Existing commercial markets, plus assets in late Phase 3 or regulatory submission: multiple products, segments, age groups, channels and country-specific dynamics to model.
-
Bottom-up, fully interactive demand forecast model including DemandENGINE™ technology (Excel .xlsx file, downloadable)
DemandENGINE™ is VacZine Analytics' AI-enabled forecasting technology. It tracks every patient from first dose to booster, never double-counting, across age groups, risk groups and payer channels. Shape the launch uptake curve, set how fast protection wanes and when boosters are due, adjust compliance across the schedule, or switch funding decisions on and off, and see the whole market respond in seconds.
- Executive strategic presentation (PDF file, downloadable)
- Country and channel-level segmentation
- One-hour post-delivery walkthrough with a senior analyst
- Defined free support period, 1 month post-delivery*
- Extra analyst support packages available e.g. quarterly tracking
- Standard global team licenceUp to 10 users, with access to the online members area.
Flagship Global
MarketVIEW
Influenza, travel vaccines, dengue and similarly complex markets: extensive geographic coverage, differentiated products, historical datasets and large forecast systems.
-
Multi-country, multi-product, fully interactive forecast system including DemandENGINE™ technology (Excel .xlsx file, downloadable)
DemandENGINE™ is VacZine Analytics' AI-enabled forecasting technology. It tracks every patient from first dose to booster, never double-counting, across age groups, risk groups and payer channels. Shape the launch uptake curve, set how fast protection wanes and when boosters are due, adjust compliance across the schedule, or switch funding decisions on and off, and see the whole market respond in seconds.
- Executive strategic presentation (PDF file, downloadable)
- Historical datasets and scenario modelling
- One-hour post-delivery walkthrough with a senior analyst
- Defined free support period, 1 month post-delivery*
- Extra analyst support packages available e.g. quarterly tracking
- Standard global team licenceUp to 10 users, with access to the online members area.
MarketVIEW Tracker: keep your forecast live
A study is a snapshot. The Tracker keeps your MarketVIEW model current after delivery, with a structured update every quarter, so your forecast reflects new data, approvals and competitor moves rather than last year's picture.
- Quarterly refresh of the model inputs, assumptions and forecast outputs
- Short change summary each quarter: what moved, why, and the effect on the forecast
- Updated interactive model, including DemandENGINE™ assumptions where your study includes it
- Senior analyst review call each quarter
Available with
Priced as a share of the original study fee and confirmed in your written quotation. Your 1-month free support period is unaffected; Tracker terms start once it ends. Rapid updates after a major event can be quoted when needed.
Prices shown are indicative starting prices for the standard global team licence specified in your study quotation, and exclude VAT where applicable. Final pricing reflects geographic coverage, market complexity, forecast granularity, licence requirements and any requested customisation or updates.
Clear inclusions, with additional requirements quoted separately.
Every MarketVIEW study licence includes a defined core package. Wider rights, bespoke analysis and future updates are always identified and quoted separately.
Included in the indicative price
- Strategic analysis: disease background, competitive landscape and target product profile
- Editable, fully interactive Microsoft Excel forecast model
- Standard global team licence - internal use by one named business function or project team within the contracting legal entity
- Pre-purchase scope confirmation by email or call
Quoted separately
- Enterprise licence - unrestricted internal use throughout the contracting legal entity
- Group licence - internal use by the contracting company and its named affiliates or legal entities
- External distribution rights
- Bespoke analysis or model customisation
- Country or segment extensions beyond the base scope
- MarketVIEW Tracker (quarterly updates) and any other ongoing intelligence programme
One standard licence, with wider rights available.
The headline price covers the standard global team licence. The two wider tiers are quoted individually once we understand who else in your organisation needs access.
Internal use by one named business function or project team within the contracting legal entity, as specified in the quotation. The study may not be circulated outside the licensed team.
Unrestricted internal use throughout the contracting legal entity.
Internal use by the contracting company and the named affiliates or legal entities specified in the quotation.
Pricing, briefly.
Is £12,995 the full price, or a "from" figure?
£12,995 is the current starting price for a standard-scope Emerging Opportunity MarketVIEW under our global team licence. Established commercial markets, flagship categories, broader geographical coverage and wider organisational rights are quoted separately. Your written quotation confirms the final study scope, licence and fixed price.
Does the price include VAT?
No. Prices shown are exclusive of VAT where applicable, and are quoted in GBP unless we agree otherwise with you.
What if several teams or entities need access?
The published price covers the standard global team licence - internal use by one named business function or project team within the contracting legal entity. Enterprise and group licences are quoted separately once we know the scope. See Licence scope above.
What is the MarketVIEW Tracker, and is it compulsory?
It is an optional add-on that keeps your study current with a structured update every quarter. It is not compulsory and is not part of the indicative starting prices above. It is priced as a share of the original study fee and confirmed in your written quotation, and is available with Established Market and Flagship Global studies.
How do I obtain a fixed quotation?
Tell us which study and licence scope you require. After brief scoping by email or call, we will provide a fixed written quotation, normally within two working days.
Get a quotation scoped to your market
Tell us the vaccine category and licence you need, and we will come back with a fixed, written quotation - usually within two working days.
← All reports Request a quotation